HPV mRNA testing in cervical cancer screening

Lancet Oncol. 2022 Oct;23(10):e436. doi: 10.1016/S1470-2045(22)00486-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Early Detection of Cancer
  • Female
  • Humans
  • Papillomavirus Infections* / diagnosis
  • Papillomavirus Infections* / genetics
  • RNA, Messenger
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / genetics

Substances

  • RNA, Messenger